Volume 84, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Serum tumor necrosis factor-α (TNF-α) was evaluated in -infected patients at admission. The median TNF-α concentration in the non-survivor group was determined to be 261.0 pg/mL, in contrast to 69.5 pg/mL in the survivor group ( = 0.001). Hence, serum TNF-α concentration may potentially be an early predictor of the mortality in patients with septicemia.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Hlady WG, Klontz KC, , 1996. The epidemiology of Vibrio infections in Florida, 1981–1993. J Infect Dis 173: 11761183.[Crossref] [Google Scholar]
  2. Bullen JJ, Spalding PB, Ward CG, Gutteridge JM, , 1991. Hemochromatosis, iron, and septicemia caused by Vibrio vulnificus . Arch Intern Med 151: 16061609.[Crossref] [Google Scholar]
  3. Simpson AJ, Smith MD, Weverling GJ, Suputtamongkol Y, Angus BJ, Chaowagul W, White NJ, van Deventer SJ, Prins JM, , 2000. Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis. J Infect Dis 181: 621625.[Crossref] [Google Scholar]
  4. Waage A, Halstensen A, Espevik T, , 1987. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 14: 35557.[Crossref] [Google Scholar]
  5. Hor LI, Chang YK, Chang CC, Lei HY, Ou JT, , 2000. Mechanism of high susceptibility of iron-overloaded mouse to Vibrio vulnificus infection. Microbiol Immunol 44: 871878.[Crossref] [Google Scholar]
  6. Shin SH, Shin DH, Ryu PY, Chung SS, Rhee JH, , 2002. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients' sera. FEMS Immunol Med Microbiol 33: 133138.[Crossref] [Google Scholar]
  7. Kim HS, Kim DM, Neupane GP, Lee YM, Yang NW, Jang SJ, Jung SI, Park KH, Park HR, Lee CS, Lee SH, , 2008. Comparison of conventional, nested, and real-time PCR assays for rapid and accurate detection of Vibrio vulnificus . J Clin Microbiol 46: 29922998.[Crossref] [Google Scholar]
  8. Kim DM, Lee YM, Back JH, Yang TY, Lee JH, Song HJ, Shim SK, Park MY, , 2010. A serosurvey of Orientia tsutsugamushi from patients with scrub typhus. Clin Microbiol Infect 16: 447451.[Crossref] [Google Scholar]
  9. Kim DM, Lym Y, Jang SJ, Han H, Kim YG, Chung CH, Hong SP, , 2005. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus . Antimicrob Agents Chemother 49: 34893491.[Crossref] [Google Scholar]
  10. Powell JL, Wright AC, Wasserman SS, Hone DM, Morris JG, Jr, 1997. Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models. Infect Immun 65: 37133718. [Google Scholar]
  11. Espat NJ, Auffenberg T, Abouhamze A, Baumhofer J, Moldawer LL, Howard RJ, , 1996. A role for tumor necrosis factor-alpha in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction. Ann Surg 223: 428433.[Crossref] [Google Scholar]
  12. Kumar A, Haery C, Paladugu B, Kumar A, Symeoneides S, Taiberg L, Osman J, Trenholme G, Opal SM, Goldfarb R, Parrillo JE, , 2006. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. J Infect Dis 193: 251258.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 31 May 2010
  • Accepted : 18 Nov 2010
  • Published online : 04 Mar 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error